Arg347Cys polymorphism of α1A-adrenoceptor gene is associated with blood pressure response to nifedipine GITS in Chinese hypertensive patients

Journal of Human Genetics

Volumn 54, Issue 6, 2009, Pages 360-364

  Zhang, Yan ^a   Hong, Xiumei ^b   Liu, Haipeng ^a   Huo, Yong ^a   Xu, Xiping ^b  

^a PEKING UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Adrenoceptor; Blood pressure; Hypertension; Nifedipine; Polymorphism; Response

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; NIFEDIPINE; ADRENERGIC RECEPTOR ALPHA(1A); ALPHA 1 ADRENERGIC RECEPTOR; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CHINESE; DRUG BLOOD LEVEL; DRUG RESPONSE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; AGED; ASIAN; DRUG EFFECT; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE AGED; PATHOLOGY;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, ALPHA-1; VASODILATOR AGENTS;

EID: 67650819327     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2009.42     Document Type: Article

References (28)

1. Brown, M. J., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G. & Rosenthalm, T. et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 356, 366-372 (2000).
2. Krakoff, L. R. Effectiveness of nifedipine gastrointestinal therapeutic system for treatment of hypertension: results of the MATH Trial. J. Cardiovasc. Pharmacol. 21, S14-S17 (1993).
3. Hingorani, A. D., Jia, H., Stevens, P. A., Hopper, R., Dickerson, J. E. & Brown, M. J. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J. Hypertens. 13, 1602-1609 (1995).
4. Psaty, B. M., Smith, N. L., Heckbert, S. R., Vos, H. L., Lemaitre, R. N., Reiner, A. P. et al. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA 287, 1680-1689 (2002).
5. Moffett, S., Mouillac, B., Bonin, H. & Bouvier, M. Altered phosphorylation and desensitization patterns of a human beta 2-adrenergic receptor lacking the palmitoy-lated Cys341. EMBO J. 12, 349-356 (1993).
6. O'Dowd, B. F., Hnatowich, M., Regan, J. W., Leader, W. M., Caron, M. G. & Lefkowitz, R. J. Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. J. Biol. Chem. 263, 15985-15992 (1988).
7. Green, S. A., Turki, J., Innis, M. & Liggett, S. B. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33, 9414-9419 (1994).
8. Benetos, A., Cambien, F., Gautier, S., Ricard, S., Safar, M., Laurent, S. et al. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 28, 1081-1084 (1996).
9. Dudley, C., Keavney, B., Casadei, B., Conway, J., Bird, R. & Ratcliffe, P. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes. J. Hypertens. 14, 259-262 (1996).
10. Nair, R. & Dyer, D. C. Pharmacological characterization of alpha 1-adrenoceptors in porcine uterine artery. Eur. J. Pharmacol. 312, 45-51 (1996).
11. Rudner, X. L., Berkowitz, D. E., Booth, J. V., Funk, B. L., Cozart, K. L., D'Amico, E. B. et al. Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation 100, 2336-2343 (1999).
12. Testa, R., Guarneri, L., Taddei, C., Poggesi, E., Angelico, P., Sartani, A. et al. Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery. J. Pharmacol. Exp. Ther. 277, 1237-1246 (1996).
13. Villalobos-Molina, R., Lopez-Guerrero, J. J. & Ibarra, M. Alpha 1D- and alpha 1A-adrenoceptors mediate contraction in rat renal artery. Eur. J. Pharmacol. 322, 225-227 (1997).
14. Rokosh, D. G. & Simpson, P. C. Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc. Natl Acad. Sci. USA 99, 9474-9479 (2002).
15. 2+ in smooth muscle. Nature 329, 333-335 (1987).
16. Han, C., Li, J. & Minneman, K. P. Subtypes of alpha 1-adrenoceptors in rat blood vessels. Eur. J. Pharmacol. 190, 97-104 (1990).
17. Eckert, R. E., Karsten, A. J., Utz, J. & Ziegler, M. Regulation of renal artery smooth muscle tone by alpha1-adrenoceptors: role of voltage-gated calcium channels and intracellular calcium stores. Urol. Res. 28, 122-127 (2000).
18. Shibata, K., Hirasawa, A., Moriyama, N., Kawabe, K., Ogawa, S. & Tsujimoto, G. Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br. J. Pharmacol. 118, 1403-1408 (1996).
19. Cockroft, J. R., Gazis, A. G., Cross, D. J., Wheatley, A., Dewar, J., Hall, I. P. et al. β2-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 36, 371-375 (2000).
20. Dishy, V., Sofowora, G. G., Xie, H. G., Kim, R. B., Byrne, D. W., Stein, C. M. et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N. Engl. J. Med. 345, 1030-1035 (2001).
21. Garovic, V. D., Joyner, M. J., Dietz, N. M., Boerwinkle, E. & Turner, S. T. β2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J. Physiol. 546, 583-589 (2003).
22. Gratze, G., Fortin, J., Labugger, R., Binder, A., Kotanko, P., Timmermann, B. et al. Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 33, 1425-1430 (1999).
23. Hoit, B. D., Suresh, D. P., Craft, L., Walsh, R. A. & Liggett, S. B. Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am. Heart J. 139, 537-542 (2000).
24. Liljedahl, U., Karlsson, J., Melhus, H., Kurland, L., Lindersson, M., Kahan, T. et al. A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. Pharmacogenetics 13, 7-17 (2003).
25. Turner, S. T., Chapman, A. B., Schwartz, G. L. & Boerwinkle, E. Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. Am. J. Hypertens. 16, 834-839 (2003).
26. Banzet, O., Colin, J. N., Thibonnier, M., Singlas, E., Alexandre, J. M. & Corvol, P. Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine. Eur. J. Clin. Pharmacol. 24, 145-150 (1983).
27. Taburet, A. M., Singlas, E., Colin, J. N., Banzet, O., Thibonnier, M. & Corvol, P. Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects. Hypertension 5, II 29-33 (1983).
28. Chung, M., Reitberg, D. P., Gaffney, M. & Singleton, W. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine. Am. J. Med. 83, 10-14 (1987).